Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
96studies shown
Showing 61-72 of 96
Other study type icon
UnknownNCT05780853

A Game-based Neurodevelopmental Assessment for Young Children

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 3 Years to 8 Years
Countries
United Kingdom
Sponsor
Brightlobe Limited
Condition
ADHD
Other study type icon
CompletedNCT01395160

Female Experiences and Brain Activity

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHD, BipolarityObservationalA study where researchers collect information without assigning a treatment.From 25 Years to 45 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
ADHD, Bipolarity
Drug study icon
CompletedNCT00190684

Long-Term, Open Label Atomoxetine Study

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 6 Years to 18 Years
Countries
United States, Australia, France, ...
Sponsor
Eli Lilly and Company
Condition
ADHD
Device study icon
Not recruitingISRCTN93932965

Understanding sensory experiences of neurodiverse adolescents in mainstream secondary schools

This public ISRCTN record appears to relate to adhd. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDOtherFrom 10 Years to 19 Years
Countries
United Kingdom
Sponsor
Sheffield Hallam University
Condition
ADHD
Drug study icon
CompletedEUCTR 2007-002111-82

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROS® methylphenidate (54 and 72 mg/day) i...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
France, United Kingdom, Belgium, ...
Sponsor
Janssen-Cilag International N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium
Condition
ADHD
Drug study icon
CompletedEUCTR 2009-011745-94

A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel-group Study to Compare the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
France, United Kingdom, Belgium, ...
Sponsor
Shire Pharmaceutical Development Limited
Condition
ADHD
Drug study icon
CompletedEUCTR 2008-000720-10

A Phase III, Double- Blind, Placebo- Controlled, Randomised Withdrawal, Multicentre, Extension, Safety and Efficacy of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17 with A...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about ADHD.

ADHDDrug
Countries
France, United Kingdom, Belgium, ...
Sponsor
Shire Pharmaceutical Development Limited
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.